Value of the First Post-Transplant Biopsy for Predicting Long-Term Cardiac Allograft Vasculopathy (CAV) and Graft Failure in Heart Transplant Patients

• Carlos A. Labarrere ,

  * E-mail: clabarrere@iuhealth.org

  Affiliation Experimental Pathology, Methodist Research Institute, Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States of America

  ⨯
• John R. Woods,

  Affiliation Outcomes Research, Methodist Research Institute, Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States of America

  ⨯
• James W. Hardin,

  Affiliation Epidemiology and Biostatistics, University of South Carolina, Columbia, South Carolina, United States of America

  ⨯
• Gonzalo L. Campana,

  Affiliation Experimental Pathology, Methodist Research Institute, Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States of America

  ⨯
• Miguel A. Ortiz,

  Affiliation Experimental Pathology, Methodist Research Institute, Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States of America

  ⨯
• Beate R. Jaeger,

  Affiliation Dr. Stein und Kollegen, Mönchengladbach, Germany

  ⨯
• Lee Ann Baldridge,

  Affiliation Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America

  ⨯
• Douglas E. Pitts,

  Affiliation St Vincent Medical Group, St Vincent Hospital, Indianapolis, Indiana, United States of America

  ⨯
• Philip C. Kirlin

  Affiliation Transplant Center, Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States of America

  ⨯